During the global COVID-19 outbreak, BioEcho developed a rapid extraction protocol that reduced the isolation of SARS-CoV-2-RNA to just a few minutes. Currently, BioEcho offers a CE-marked viral RNA/DNA extraction kit and is implementing automated solutions that will allow customers to increase their diagnostics throughput.
New entrant at Celyad
AppointmentsBelgium-based Celyad has had a new CMO since April: Dr Charles Morris.
Mogrifiy completes Series A financing round
Latest NewsCell reprogramming specialist Mogrify Ltd has announced the second closing of its Series A financing of $17m, bringing the total raised to $33m in this round.
COVID-19 vaccine for poor countries
Latest NewsModerna Inc. has signed a COVID-19 vaccine supply agreement with vaccination alliance Gavi.
Increase viral RNA extraction throughput with automation
Sponsored PublicationsDuring the global COVID-19 outbreak, BioEcho developed a rapid extraction protocol that reduced the isolation of SARS-CoV-2-RNA to just a few minutes. Currently, BioEcho offers a CE-marked viral RNA/DNA extraction kit and is implementing automated solutions that will allow customers to increase their diagnostics throughput.
ADCendo ApS raises €51m in Series A financing
Latest NewsDanish ADCendo ApS will use the funds from a Series A investment to advance Antibody-Drug Conjugates (ADCs) entering cancer cells through endocytic receptors.
New Kurma-Partner appointed
AppointmentsThe Venture Capital Company Kurma Partners, based in Paris and Munich, appointed Jean-Francois Rivassou as new Partner.
DNA Script bags DARPA funding
Latest NewsDNA Script will receive a $5m DARPA grant as part of the agency’s Nucleic Acids On-Demand World-Wide Program to prevent the next viral pandemic.
First malaria vaccine meets WHO efficacy criteria
Latest NewsResearchers at Novavax and from the University of Oxford reported an efficacy of 77% of their malaria vaccine, R21/Matrix-M from a Phase II trials in Burkina Faso.
European COVID-19 antibody enters Phase III testing
Latest NewsGSK’s and Vir Therapeutics’ COVID-19 antibody treatment VIR-7831 has entered Phase III testing within the UK’s COVID-19 drug testing platform, AGILE
J&J starts European COVID-19 vaccine roll-out
Latest NewsAfter a positive re-evaluation of J&J’s COVID-19 vaccine by the European Medicines Agency (EMA), J&J has re-started to ship 55 million doses to the EU.